Renal Function in Patients with Thalassemia Major Receiving Exjade(®) Dispersible Tablets and a New Film-coated Tablet Formulation of Deferasirox (Nanojade(®))

BACKGROUND: In patients with β-thalassemia major (TM), one of the long-term complications of regular blood transfusion is renal dysfunction. The purpose of the current study was to evaluate the renal function in TM patients receiving Exjade(®) dispersible tablets and a new film-coated tablet formula...

Descripción completa

Detalles Bibliográficos
Autores principales: Falahati, Vahid, Ghasemi, Ali, Safari, Mohammad Reza, Ghaffari, Kazem, Yousefichaijan, Parsa, Zamanian, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744082/
https://www.ncbi.nlm.nih.gov/pubmed/36518868
http://dx.doi.org/10.4103/abr.abr_89_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744082/
https://www.ncbi.nlm.nih.gov/pubmed/36518868
http://dx.doi.org/10.4103/abr.abr_89_21

Ejemplares similares